Atu027

· Silence Therapeutics GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Atu027, covering 2013-04-09 to 2016-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) [Phase 1, Phase 2]